◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

VARIAN MEDICAL SYSTEMS INC

CIK: 203527 SIC: 3845
$3.12B
Revenue
$277.50M
Net Income
43.92%
Gross Margin
10.60%
Op. Margin
$621.90M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 35 quarterly reports available
Breakdown Q1 2021
(Dec 31, 2020)
Q4 2020
(Sep 30, 2020)
Q3 2020
(Jun 30, 2020)
Q2 2020
(Mar 31, 2020)
Q1 2020
(Dec 31, 2019)
Q4 2019
(Sep 30, 2019)
Q3 2019
(Jun 30, 2019)
+ Total Revenue $778.80M $850.50M $694.30M $794.50M $828.90M $878.90M $825.80M
Revenue Growth % (YoY) -6.0% -3.2% -15.9% nan% nan% nan% nan%
Cost of Revenue $419.80M $475.80M $395.80M $457.30M $462.10M $494.30M $474.40M
+ Gross Profit $359.00M $374.70M $298.50M $337.20M $366.80M $384.60M $351.40M
Gross Margin % 46.1% 44.1% 43.0% 42.4% 44.3% 43.8% 42.6%
Operating Expenses $241.80M $276.30M $238.60M $282.30M $256.80M $273.80M $297.50M
Research & Development $72.20M $77.20M $65.30M $71.00M $67.10M $65.20M $62.10M
Selling General & Admin $161.90M $174.50M $145.00M $175.30M $177.00M $181.60M $153.60M
+ Operating Income $117.20M $98.40M $59.90M $54.90M $110.00M $110.80M $53.90M
Operating Margin % 15.0% 11.6% 8.6% 6.9% 13.3% 12.6% 6.5%
Interest Expense $1.30M $2.10M $2.90M $4.30M $4.70M $4.80M $1.80M
Interest Income $2.80M $1.60M $2.70M $3.10M $3.00M $3.50M $3.70M
Other Income/Expense $5.70M $10.10M $25.10M - - $900.00K $4.20M
Income Before Tax $124.40M - $84.80M $52.80M $112.70M $110.40M $60.00M
Income Tax Expense $27.60M $31.50M $23.90M $9.70M $23.80M $40.00M $30.50M
+ Net Income $96.50M $76.60M $61.20M $43.20M $88.20M $70.70M $29.40M
Net Margin % 12.4% 9.0% 8.8% 5.4% 10.6% 8.0% 3.6%
Basic EPS 1.06 0.84 0.67 0.48 0.97 0.78 0.32
Diluted EPS 1.05 0.83 0.67 0.47 0.96 0.77 0.32
Basic Shares Outstanding 91.4M 100K 90.8M 90.7M 90.9M - 91.0M
Diluted Shares Outstanding 92.2M 100K 91.2M 91.4M 91.7M - 91.8M
Breakdown Q1 2021
(Dec 31, 2020)
Q4 2020
(Sep 30, 2020)
Q3 2020
(Jun 30, 2020)
Q2 2020
(Mar 31, 2020)
Q1 2020
(Dec 31, 2019)
Q4 2019
(Sep 30, 2019)
Q3 2019
(Jun 30, 2019)
Cash & Cash Equivalents $773.30M $766.10M $769.20M $667.80M $721.90M $531.40M $520.70M
Accounts Receivable $1.03B $1.07B $987.40M $1.00B $1.08B $1.11B $1.05B
Inventory $571.70M $516.30M $600.40M $604.00M $597.40M $551.50M $529.30M
Other Current Assets $267.00M $254.80M $274.70M $224.30M $248.50M $206.20M $237.00M
Total Current Assets $2.64B $2.60B $2.63B $2.50B $2.65B $2.40B $2.34B
Property Plant & Equipment - - - $341.90M - $311.50M $307.40M
Goodwill $627.70M $623.90M $607.40M $614.70M $612.40M $612.20M $566.90M
Intangible Assets $265.00M $271.30M $265.70M $281.60M $290.90M $300.70M $273.10M
Other Non-current Assets $460.70M $416.30M $387.40M $387.40M $370.30M $397.20M $384.80M
Total Assets $4.53B $4.46B $4.45B $4.34B $4.45B $4.10B $3.97B
Accounts Payable $206.50M $194.90M $164.50M $198.40M $215.30M $248.50M $226.10M
Short-term Debt $210.00M $355.00M $580.00M $520.00M $542.00M $410.00M $400.00M
Accrued Liabilities $482.70M $522.40M $468.50M $433.20M $471.20M $459.50M $433.10M
Deferred Revenue $845.70M $782.20M $778.40M $798.10M $817.90M $766.00M $749.70M
Total Current Liabilities $1.74B $1.85B $1.99B $1.95B $2.05B $1.88B $1.81B
Other Non-current Liabilities $431.70M $421.80M $417.30M $423.10M $453.30M $440.10M $400.10M
Total Liabilities $2.28B $2.38B $2.51B $2.47B $2.59B $2.32B $2.21B
Common Stock $91.80M $91.20M $90.90M $90.70M $90.70M $90.80M $91.00M
Retained Earnings $1.23B $1.13B $1.05B $993.70M $983.20M $934.00M $890.70M
Total Stockholders Equity $2.24B $2.08B $1.93B $1.86B $1.85B $1.77B $1.74B
Total Liabilities & Equity $4.53B $4.46B $4.45B $4.34B $4.45B $4.10B $3.97B
Breakdown Q1 2021
(Dec 31, 2020)
Q4 2020
(Sep 30, 2020)
Q3 2020
(Jun 30, 2020)
Q2 2020
(Mar 31, 2020)
Q1 2020
(Dec 31, 2019)
Q4 2019
(Sep 30, 2019)
Q3 2019
(Jun 30, 2019)
Net Income $96.50M $76.60M $61.20M $131.40M $88.20M $70.70M $29.40M
Stock-based Compensation $16.70M $13.30M $30.60M $26.20M $14.90M $12.70M $35.20M
Deferred Income Tax $14.90M $24.80M $2.10M $-8.70M - $10.00M $8.90M
Change in Receivables $-29.10M $49.10M $-84.30M $-49.90M $-29.50M $34.00M $77.70M
Change in Inventory $52.50M $-87.50M $47.70M $53.70M $44.90M $28.50M $78.40M
Change in Payables $8.00M $27.40M $-94.30M $-54.70M $-32.70M $19.80M $29.90M
Operating Cash Flow $141.40M $266.60M $217.50M $134.50M $112.60M $117.80M $254.00M
Capital Expenditure $16.80M $29.30M $55.00M $37.00M $22.60M $14.30M $43.70M
Acquisitions $500.00K $27.80M $8.40M $8.40M $1.70M $90.60M $485.60M
Purchases of Investments $10.30M - $21.30M - - $3.00M $29.80M
Investing Cash Flow $-27.60M $-63.00M $-77.30M $-36.20M $-15.10M $-108.00M $-523.70M
Debt Repayment - - - $105.00M $11.00M $206.50M $430.00M
Stock Repurchased - - $86.20M $86.20M $43.80M $32.50M $134.20M
Financing Cash Flow $-100.20M $-204.40M $111.30M $43.50M $103.40M $-14.80M $294.00M
Net Change in Cash $7.30M $-4.70M $246.40M $144.90M $198.10M $1.20M $26.50M
SEC Filing Format - Data shown as it appears in the Q1 2021 (10-Q) filing Period ended: Dec 31, 2020
Condensed Consolidated Statements of Operations
Description Dec 31, 2020
Current Prior Year
Total Revenue $778.80M $828.90M
Cost of Revenue $419.80M $462.10M
Gross Profit $359.00M $366.80M
Operating Expenses $241.80M $256.80M
Research & Development $72.20M $67.10M
Selling General & Admin $161.90M $177.00M
Operating Income $117.20M $110.00M
Interest Expense $1.30M $4.70M
Interest Income $2.80M $3.00M
Other Income/Expense $5.70M $4.40M
Income Before Tax $124.40M $112.70M
Income Tax Expense $27.60M $23.80M
Net Income $96.50M $88.20M
Basic EPS 1.06 0.97
Diluted EPS 1.05 0.96
Basic Shares Outstanding $91.40M $90.90M
Diluted Shares Outstanding $92.20M $91.70M
Condensed Consolidated Balance Sheets
Description Dec 31, 2020 Sep 30, 2020
Cash & Cash Equivalents $773.30M $766.10M
Accounts Receivable $1.03B $1.07B
Inventory $571.70M $516.30M
Other Current Assets $267.00M $254.80M
Total Current Assets $2.64B $2.60B
Goodwill $627.70M $623.90M
Intangible Assets $265.00M $271.30M
Other Non-current Assets $460.70M $416.30M
Total Assets $4.53B $4.46B
Accounts Payable $206.50M $194.90M
Short-term Debt $210.00M $355.00M
Accrued Liabilities $482.70M $522.40M
Deferred Revenue $845.70M $782.20M
Total Current Liabilities $1.74B $1.85B
Other Non-current Liabilities $431.70M $421.80M
Total Liabilities $2.28B $2.38B
Common Stock $91.80M $91.20M
Retained Earnings $1.23B $1.13B
Total Stockholders Equity $2.24B $2.08B
Total Liabilities & Equity $4.53B $4.46B
Condensed Consolidated Statements of Cash Flows
Description Dec 31, 2020
Current Prior Year
Net Income $96.50M $88.20M
Stock-based Compensation $16.70M $14.90M
Deferred Income Tax $14.90M $1.80M
Change in Receivables $-29.10M $-29.50M
Change in Inventory $52.50M $44.90M
Change in Payables $8.00M $-32.70M
Operating Cash Flow $141.40M $112.60M
Capital Expenditure $16.80M $22.60M
Acquisitions $500.00K $1.70M
Purchases of Investments $10.30M -
Investing Cash Flow $-27.60M $-15.10M
Stock Repurchased - $43.80M
Financing Cash Flow $-100.20M $103.40M
Net Change in Cash $7.30M $198.10M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...